
|Articles|January 4, 2017
FDA's Criminal Investigation Head to Leave as Trump Takes Office
January 04, 2017
Advertisement
Reuters reports that George Karavetsos, director of the Food and Drug Administration's Office of Criminal Investigations (OCI), is to leave the agency. Karavetsos has been OCI director since January 2015. The report adds that Karavestos's "last day will be Jan. 20, the day Donald Trump is sworn in as president".
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Modern Policy Concerns Stemming from 340B
2
Funding Roundup: Silence Therapeutics, AbCellera Announce IPO Pricing, Beyang, Remepy Close Series A Financing
3
2026 Emerging Pharma Leaders
4
Pharmaceutical Executive Daily: Mereo BioPharma Enters Option and License Agreement with Sentynl Therapeutics
5




